A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral Fracture

NCT04543682 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Proximal Humeral Fracture

Interventions

DRUG: 0.125 ng/kg/min Iloprost
DRUG: 0.25 ng/kg/min Iloprost
PROCEDURE: open reduction and internal fixation with an angular stable plate (PHILOS)

Sponsor

Charite University, Berlin, Germany